MENU
Corcept Therapeutics (CORT) Ownership - Who owns Corcept Therapeutics?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
149 Commonwealth Drive
Phone
+1 650 327-3270
Employees
352
Web
https://www.corcept.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.59B
P/E Ratio
30.42
Total Cash
473.16M
Projected Growth
N/A
Total Debt
5.67M
Revenue
569.61M
Risk (Beta)
0.63
Dividend Yield
N/A
Total Cash/Share
4.53
Total Debt/Equity
374.71
Revenue/Share
5.14 USD as % of share price
Fundamentals
CORT
Capitalization
3.59B
P/E Ratio
30.42
Risk (Beta)
0.63
Dividend Yield
N/A
Total Cash
473M
Total Cash/Share
4.53
Total Debt
5.67M
Total Debt/Equity
374.71
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.14%
Revenue
570M
ROE
N/A
Book Value
596M
P/B Ratio
6.02
Cash Flow
N/A
Earnings
1.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
134K
Current Ratio
5.57
Current Revenue Per Employee
465329.53
Dividends Per Share - Security
N/A
EBITDA
129M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.46
Revenue To Assets
20.17
Shares Held By Institutions
3.89B
Shares Outstanding - Current
104M
Total Liabilities
118M
Total Volume MTD
N/A
Value
-1
Gain YTD
4.895
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a maker of drugs for the treatment of severe psychiatric and neurological diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
149 Commonwealth Drive
Phone
+1 650 327-3270
Employees
352
Web
https://www.corcept.com